Pathogenesis of acute cholecystitis after gastrectomy.

Area of Science:

• Gastroenterology
• Surgical Oncology
• Biliary System Physiology

Background:

• Gastrectomy, a surgery for gastric conditions, is associated with an increased incidence of gallbladder diseases.
• Post-gastrectomy biliary complications, such as acute cholecystitis, are often linked to impaired gallbladder motility and biliary stasis.

Purpose of the Study:

• To investigate the impact of gastrectomy on gallbladder contractile motility.
• To evaluate the role of biliary stasis in the development of gallbladder diseases after gastrectomy.
• To assess the therapeutic effect of naloxone on post-gastrectomy gallbladder dyskinesia and biliary sludge formation.

Main Methods:

• Prospective study involving ultrasonography to assess gallbladder size, biliary sludge, and motility.
• Measurement of gallbladder contraction in response to stimuli (egg yolk, caerulein) before and after gastrectomy.
• Evaluation of the effect of daily naloxone administration on gallbladder function and sludge formation.

Main Results:

• Enlargement of the gallbladder, biliary sludge accumulation, and hypomotility were frequently observed within one month post-gastrectomy.
• Gallbladder contraction gradually recovered to near preoperative levels within three months.
• Daily naloxone administration significantly improved gallbladder dyskinesia and reduced biliary sludge incidence within one month.

Conclusions:

• Biliary stasis due to impaired gallbladder motility is a significant factor in acute cholecystitis following gastrectomy.
• Gallbladder function can recover over time, but early intervention may be beneficial.
• Naloxone shows potential as a therapeutic agent to mitigate gallbladder dysfunction and biliary sludge formation after gastrectomy.